We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Oxford Biodynamics Plc | OBD | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.84 | 61.76% | 2.20 | 16:35:10 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.34 | 1.34 | 2.19 | 2.20 | 1.36 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 14/10/2024 06:12 by bones698 Ouch so pretty much out of cash and sales slow . Far too late cutting costs and the sale of such immature assets with very small revenue will not yield a great amount plus totally the wrong time to sell . The spin off wouldn't realise much value either .Basically what they are sating is selling upmamd shut up shop as they have no funds . Was obvious this was coming and the awful equity markets mean investors will be the ones that suffer yet again just like. Dest . |
Posted at 07/10/2024 06:33 by boonkoh One of the most bizarre RNS I have ever seen.Instead of focusing on the financing impact of not winning the grant, they stick their head in the sand and write a long congratulations for the winning consortium.Instead what would have served investors better is an update on current trading and cash position, and be honest if further funds are now required. Truly shocking that management still continue to run this company foelr their benefit, and not for shareholders. The only positive news is that it looks like a new investor has popped up with >3%... One with experience in patents and IP (albeit not in biotech?). (i hold in the Boon fund) |
Posted at 10/9/2024 08:50 by bones698 Unfortunately looks like another discounted fund raise is coming here . The losses are simply far too high for a company generating very little revenue and some way from break even . Explains the share price falling off a cliff . Could be anything as low as 2p fund raise as they tend to leave it late . Decent product but poorly managed and spending far too much cash too quickly .What's more alarming is they have not once looked to save money along the way and instead spent and lost millions for years . Total contempt for investors imo . |
Posted at 13/3/2024 19:57 by hatfullofsky 1.25m is just the primary bid raise they are raising another 9m from existing and new investors |
Posted at 13/3/2024 19:51 by jaf111 Good that HL on the ball….i wonder what you could have done though if you weren’t an existing shareholder?The Primary Bid blurb does state the fund raise is for both existing and new investor…..i do wonder how possible this would be for new investors in view of the tight timescale? |
Posted at 13/3/2024 17:18 by jaf111 Doe anyone know how to participate in the fund raise with Interactive Investors….Pri |
Posted at 05/1/2024 16:31 by waldron Notice of Results and Investor Webinar21 December 2023 - Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch(R) 3D genomics platform expects to announce its results for the year ended 30 September 2023 on Wednesday 17 January 2024. Following release of the results, the Company's management team will conduct a live presentation via the Yellowstone Advisory webinar platform to investors, at 3pm GMT on Wednesday 17 January 2024. THINGS SHOULD BECOME CLEARER AS TO OUTLOOK AD RESULTS APPROACHED CHUCKLE AND CHEERS |
Posted at 21/12/2023 11:06 by yellowstoneadvisory Oxford Biodynamics will release FY results for the year to 30 September 2023 on 17 January 2024.There will be a presentation for investors at 3pm that day and you can register for the event here. |
Posted at 19/12/2023 17:51 by rar100 I can't really understand the lack of news from the Co. I presume they are busy with a hell of a lot and could have a lot to write about (with investors in mind).The lack of news makes me twitchy, it's putting me off buying a few more. |
Posted at 27/10/2023 10:16 by smithie6 Kizjak"JUN 23 Tests 97" After 7-8 months from use/dale of first tests. Data can be looked at in many ways. CiRT test, I know very little about it. Call me a cynic but 97 tests when the world has ~8 billion people. Doesn't sound like the world was banging on the door desperate to use the test. 97 !! ===== Sure, shares move in advance of success/failure & investors will be thinking about possible sales in future years. But one perhaps needs some medical knowledge to get an opinion on that & to take the time to read the tech data about this CiRT test. Many investors are not willing/able to do that. ===== I've put money today in to Nat West. p/e of 4 More attractive risk/reward imo. And nett tang. assets per share higher than the share price. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
